2019 American Transplant Congress
Belatacept Treated Patients Experience Improved Health-Related Quality of Life and Lower Symptom Distress Compared to Cyclosporine Treated Patients: An Analysis of the Benefit and Benefit-EXT Cohorts
1Terasaki Research Institute, Los Angeles, CA, 2Bristol Myers Squibb, Princeton, NJ
*Purpose: New immunosuppressive agents in transplant should not only be efficacious but also help patients feel better (i.e. lower patient reported symptoms and improve health…2019 American Transplant Congress
Predicting Deceased Donor Kidney Transplant Outcomes: Comparing KDRI/KDPI with Machine Learning
HealthTech Solutions, Inc., Coralville, IA
*Purpose: To better predict outcomes of graft survival in kidney donation and ultimately save more lives for those waiting on the list.*Methods: Machine learning methods…2019 American Transplant Congress
Evaluation Of Workplace Environment In Transplant Medicine: Harassment Should Not Be The “Reality Of Life”
*Purpose: The recent increase in publications detailing discrimination and harassment in the medical setting has brought to light potential impairments of medical professional health and…2019 American Transplant Congress
Patient-Reported Outcomes in a Prospective Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression Regimens in Kidney Transplantation
*Purpose: Previous trials have not examined differences in patient-reported outcomes (PRO) between belatacept (BELA)- and tacrolimus (TAC)-based therapies in adult kidney transplant (KTx) patients (pts).…2019 American Transplant Congress
Post-Donation Hypertension is Highly Associated with Estimated Nephron Number, Post-Donation Weight Gain, and Family History: A Prospective 5-Year Follow-Up after Living Kidney Donation
*Purpose: The rising prevalence of end-stage renal disease and chronic organ shortage subsequently calls more people upon to consider living kidney donation. Recent data, however,…2019 American Transplant Congress
Beyond Medication Education: Opportunities for Improvement in Health Education of Solid Organ Transplant Recipients
Department of Surgery, Massachusetts General Hospital, Boston, MA
*Purpose: As immunosuppressive medications are crucial to graft and patient survival, transplant centers dedicate significant resources to medication education. However, patient outcomes also depend on…2019 American Transplant Congress
“Getting Life Back” – Kidney Transplantation in the Elderly Patient
*Purpose: The number of elderly patients developing end stage renal disease (ESRD) who are eligible for kidney transplantation (KTx) is increasing, but their transplant rate…2019 American Transplant Congress
Gender Disparity: Do Female Donors Suffer from Living Kidney Donation?
*Purpose: Transplantation and optional living donation is the therapy of choice in end-stage renal disease. Due to the increase of living kidney donoration (LD), the…2019 American Transplant Congress
The Association of Health Literacy with Physical and Mental Health-Related Quality of Life in Organ Transplant Candidates
*Purpose: This study aimed to determine the association of health literacy with pre-transplant health-related quality of life (HRQOL) in adults evaluated for potential listing for…2019 American Transplant Congress
Is Kidney Transplantation Actually a Cost-Effective Alternative Also for Older Patients?
*Purpose: We aimed to study the health economic effects of kidney transplantation in a population of kidney transplant candidates > 65 years of age.*Methods: We…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 21
- Next Page »